Nagoya City University Hospital
Nagoya City University Hospital
Nagoya, Japan1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients | skin angiosarcoma | Recruiting | Phase 2 | 2026-06-24 | NCT06673628 |